Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases

Volumn 76, Issue 11, 2002, Pages 928-938

  Muratani, Tetsuro ^a   Iihara, Kiyotaka ^a   Nishimura, Takehisa ^a   Inatomi, Hisato ^a   Fujimoto, Naohiro ^a   Kobayashi, Tomoko ^a   Yamada, Yoji ^a   Takahashi, Koichi ^a   Matsumoto, Tetsuro ^a  

^a Kitakyushu Municipal Tobata Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; FROPENEM; LACTAM; OFLOXACIN; URINARY TRACT ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUROGENIC BLADDER; PROSTATE HYPERTROPHY; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; BETA-LACTAMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LACTAMS; MALE; MIDDLE AGED; OFLOXACIN; PROSTATIC HYPERPLASIA; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS;

EID: 0036877508     PISSN: 03875911     EISSN: None     Source Type: Journal    
DOI: 10.11150/kansenshogakuzasshi1970.76.928     Document Type: Article

References (0)